Outlook Therapeutics, Inc. (NASDAQ:OTLK) has a beta value of 0.41 and has seen 4,062,157 shares traded in the last trading session. The company, currently valued at $173.66 Million, closed the last trade at $1.41 per share which meant it lost -$0.08 on the day or -5.37% during that session. The OTLK stock price is -70.21% off its 52-week high price of $2.4 and 64.61% above the 52-week low of $0.499. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.56 Million shares traded. The 3-month trading volume is 2.82 Million shares.
The consensus among analysts is that Outlook Therapeutics, Inc. (OTLK) is a Buy stock at the moment, with a recommendation rating of 1.6. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 5 have rated it as a Hold, with 5 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.11.
Outlook Therapeutics, Inc. (NASDAQ:OTLK) trade information
Despite being -5.37% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Jul 23 when the OTLK stock price touched $1.73 or saw a rise of 18.5%. Year-to-date, Outlook Therapeutics, Inc. shares have moved 138.98%, while the 5-day performance has seen it change -9.62%. Over the past 30 days, the shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK) have changed 8.46%. Short interest in the company has seen 2.33 Million shares shorted with days to cover at 0.83.
Wall Street analysts have a consensus price target for the stock at $6.05, which means that the shares’ value could jump 329.08% from current levels. The projected low price target is $3.25 while the price target rests at a high of $9. In that case, then, we find that the current price level is +538.3% off the targeted high while a plunge would see the stock lose 130.5% from current levels.
Outlook Therapeutics, Inc. (OTLK) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +22.8% over the past 5 years. Earnings growth for 2020 is a modest +79.7%.